Has COVID-19 impacted your ability to pay for Olumiant? Olumiant is committed to helping you. Contact Olumiant Together at 1-844-OLUMIANT (1-844-658-6426) for information on savings and support.
Supporting You Every Step of The Way
Olumiant Together is a support program that gives you access to the Companion in CareTM team—a group of people available to help you with personalized assistance, RA resources, and support throughout your treatment.
Olumiant Together can provide you with:
- Personalized support along your treatment journey
- Assistance in confirming your insurance coverage
- Savings options for commercially insured patients
- Help in coordinating with your specialty pharmacy to receive your medication
If you do not qualify for a savings card, you can still enroll in Olumiant Together by calling 1-844-OLUMIANT (1-844-658-6426).
To get your savings card,* we need your HIPAA authorization to work on your behalf to ensure you’re paying as little as $5 or $25 a month.
As a reminder, HIPAA is the Health Insurance Portability and Accountability Act. It provides data privacy and security to protect your medical information.
*Terms and Conditions:
Offer good until 12/31/2024 or up to 36 months from patient qualification into the program, whichever comes first. Patients must first use their card by 12/31/2021. Patients must have coverage for Olumiant through their commercial drug insurance to pay as little as $5 for a 30-day supply of Olumiant. Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate annual cap set at Lilly’s sole discretion. Patients must have commercial drug insurance and prescription consistent with FDA-approved product labeling to pay as little as $25 for a 30-day supply of Olumiant. Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate annual cap of wholesale acquisition cost plus usual and customary pharmacy charges. Participation in the $25 program requires submission of a prior authorization (PA). If coverage is denied, an appeal must be submitted prior to the 5th month fill. A new PA and appeal or medical exception (ME) must be submitted every 12 months or as required by Lilly to verify coverage status and potential eligibility for the $5 program. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. This offer is invalid for patients without commercial drug insurance or whose prescription claims for Olumiant are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state patient or pharmaceutical assistance program. Offer void where prohibited by law and subject to change or discontinue without notice. Card activation is required. Subject to additional terms and conditions, which can be found here.